肿瘤患者中性粒细胞缺乏伴发热临床疗效的影响因素分析

Analysis of influencing factors on clinical efficacy of neutropenia with febrile neutropenia in tumor pa⁃tients

目的探讨影响肿瘤患者中性粒细胞缺乏伴发热(febrile neutropenia,FN)临床疗效的因素。方法回顾性分析2020年1月至2022年12月期间广州医科大学附属医院收治的130例FN患者的临床资料,根据临床疗效分为治愈、好转、无效组,对3组的一般资料和实验室检查结果进行比较,采用单因素和有序多分类logistic回归分析影响FN临床疗效的因素。结果本组FN患者的总体有效率为86.15%,单因素分析显示,3组患者粒缺时间、体能状况评分(PS评分)、降钙素原(PCT)和给药时机之间差异有统计学意义(P<0.05);有序多分类logistic回归分析显示,粒缺时间<7 d、PS评分<2、PCT<0.5 ng/mL的患者临床疗效更好。结论FN的治疗过程中应重点关注PS评分和PCT高的患者,及时采取治疗措施纠正粒缺情况以提高临床疗效。

Objective To investigate the real-world factors influencing the clinical outcome of Febrile neu⁃tropenia(FN)in oncology patients.Methods We conducted a retrospective analysis of clinical data from 130 FN patients admitted to our hospital between January 2020 and December 2022.The patients were categorized into three groups based on their clinical efficacy:cured group,effective group,and ineffective group.A comparison was made among the three groups regarding general data and laboratory examination results.Univariate and ordered multicategorical logistic regression analyses were performed to identify factors affecting the clinical efficacy of FN.Results The overall effective rate of FN in our hospital was 86.15%.Univariate analysis revealed statistically significant differences among the three patient groups regarding the duration of granulomatous defects,Physical Status Score(PS Score),procalcitonin(PCT)levels,and timing of administration(P<0.05).Ordinal multicat⁃egorical logistic regression analysis demonstrated that patients with PS scores<2,granulomatous defects lasting less than 7 days,and PCT levels below 0.5 ng/mL exhibited better clinical treatment outcomes.Conclusion In the management of FN,it is crucial to prioritize patients with high PS scores and elevated PCT levels while optimizing drug utilization to enhance clinical efficacy.Timely intervention should be implemented to address granulopathy and improve overall clinical outcomes.